Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetically supported drug target prioritization for rare diseases.

Genome medicine·2026
Same author

When splicing is not all or none: GT>GC 5' splice-site variants as a model for intermediate effects and challenges in variant classification.

HGG advances·2026
Same author

Genome-wide detection of human 5' UTR variants that impact protein translation.

American journal of human genetics·2026
Same author

Ancestry-specific performance of variant effect predictors in clinical variant classification.

bioRxiv : the preprint server for biology·2026
Same author

Predicting interaction-specific protein-protein interaction perturbations by missense variants with MutPred-PPI.

bioRxiv : the preprint server for biology·2026
Same author

A POMT2 missense substitution contributes to hypoxia adaptation in hibernating mammals.

Molecular biology and evolution·2026

Related Experiment Video

Updated: May 6, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K

Using exome data to identify malignant hyperthermia susceptibility mutations.

Stephen G Gonsalves1, David Ng, Jennifer J Johnston

  • 1* Research Associate, † Clinical Specialty Consultant, ‡ Staff Scientist, ‡‡ Branch Chief, Genetic Disease Research Branch, †† Director, National Institutes of Health Intramural Sequencing Center, National Human Genome Research Institute (NHGRI), National Institutes of Health, Bethesda, Maryland. # Research Associate, ** Professor of Human Molecular Genetics, Institute of Medical Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom. § Postdoctoral Fellow, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health. Current position: Assistant Member, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. ‖ Members of the National Institutes of Health Intramural Sequencing Center group are listed in the appendix.

Anesthesiology
|November 8, 2013
PubMed
Summary
This summary is machine-generated.

Exome sequencing identified genetic variants for malignant hyperthermia susceptibility (MHS) in an unselected population. This approach can detect at-risk individuals who are unaware of their MHS status.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

7.9K

Related Experiment Videos

Last Updated: May 6, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

7.9K

Area of Science:

  • Genetics
  • Pharmacogenomics
  • Molecular Biology

Background:

  • Malignant hyperthermia susceptibility (MHS) is a severe, inherited disorder affecting muscle calcium regulation, often triggered by anesthesia.
  • Genetic mutations in RYR1 and CACNA1S are primary causes of MHS.
  • Current screening methods may not identify all at-risk individuals.

Purpose of the Study:

  • To pilot exome sequencing as a strategy for identifying MHS-related gene variants.
  • To assess the feasibility of screening an unselected cohort for MHS mutations.
  • To evaluate the prevalence and penetrance of MHS in a general population.

Main Methods:

  • Exome sequencing was performed on 870 volunteers without prior MHS diagnosis.
  • RYR1 and CACNA1S variants were filtered based on mutation type, frequency, and pathogenicity.
  • Medical histories and pedigrees were reviewed for MHS-related conditions.

Main Results:

  • 70 RYR1 and 53 CACNA1S variants were identified in the cohort.
  • Pathogenic RYR1 variants were found in three participants without a history of MHS.
  • Many previously classified pathogenic variants were reclassified as having unknown pathogenicity.

Conclusions:

  • Exome sequencing can identify individuals at risk for MHS, including asymptomatic cases.
  • Interpreting exome sequencing variants for MHS requires careful analysis and can be challenging.
  • Screening unselected cohorts with exome sequencing is crucial for understanding MHS prevalence and penetrance.